Anti-chromatin (anti-nucleosome) autoantibodies

Autoimmunity Reviews

Volumn 1, Issue 6, 2002, Pages 321-328

  Burlingame, Rufus W ^a   Cervera, Ricard ^b  

^a INOVA DIAGNOSTICS INC   (United States)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Anti chromatin autoantibodies; DIL, drug induced lupus; DNP, deoxyribonucleoprotein; ELISA, enzyme linked immunosorbent assay.; Nucleosome; SLE, systemic lupus erythematosus; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; CHROMATIN AUTOANTIBODY; DNA; DNA ANTIBODY; H2 ANTIGEN; NUCLEOSOME AUTOANTIBODY; UNCLASSIFIED DRUG; ANTINUCLEAR ANTIBODY;

CHROMATIN; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE FUNCTION; GENE LOCUS; GENETIC ANALYSIS; GLOMERULONEPHRITIS; HUMAN; IMMUNOPRECIPITATION; KIDNEY DISEASE; LATEX AGGLUTINATION TEST; LUPOID HEPATITIS; LUPUS ERYTHEMATOSUS; LUPUS ERYTHEMATOSUS CELL TEST; NONHUMAN; NUCLEOSOME; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMIC LUPUS ERYTHEMATOSUS; ANIMAL; ANTIBODY SPECIFICITY; GENETICS; IMMUNOLOGY; LUPUS ERYTHEMATOSUS NEPHRITIS; MOUSE; NEUTROPHIL;

ANIMALS; ANTIBODIES, ANTINUCLEAR; ANTIBODY SPECIFICITY; CHROMATIN; GLOMERULONEPHRITIS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MICE; NEUTROPHILS; NUCLEOSOMES;

EID: 0041467346     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1568-9972(02)00083-6     Document Type: Review

References (40)

1. Amoura Z., Piette J.-C., Bach J.-F., Koutouzov S. The key role of nucleosomes in lupus. Arthritis Rheum. 42:1999;833-843.
2. Burlingame R.W., Boey M.L., Starkebaum G., Rubin R.L. The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. J Clin Invest. 94:1994;184-192.
3. Chabre H., Amoura Z., Piette J.-C., Godeau P., Bach J.-F., Koutouzov S. Presence of nucleosome-restricted antibodies in patients with systemic lupus erythematosus. Arthritis Rheum. 38:1995;1485-1491.
4. Burlingame R.W., Rubin R.L. Drug-induced anti-histone autoantibodies display two patterns of reactivity with substructures of chromatin. J Clin Invest. 88:1991;680-690.
5. Hargraves M.M., Richmond H., Morton R.J. Presentation of two bone marrow elements, 'Tart' cell and 'L.E.' cell. Mayo Clin Proc. 23:1948;25-28.
6. Holman H.R., Deicher H.R. The reaction of the lupus erythematosus (LE) cell factor with deoxyribonucleoprotein of the cell nucleus. J Clin Invest. 38:1959;2059-2072.
7. Klein F., Hijmans W., Schuit H.R.E. Studies on the LE Cell phenomenon II. Adsorption of the LE Cell factor. Vox Sang. 4:1959;367-375.
8. Lachman P.J. An attempt to characterize the lupus erythematosus cell antigen. Immunology. 4:1961;153-163.
9. Rekvig O.P., Hannestad K. Lupus erythematosus (LE) factors recognize both nucleosomes and viable human leukocytes. Scand J Immunol. 13:1981;597-604.
10. Dupois E.L., Drexler E., Arterberry J.D. A latex nucleoprotein test for the diagnosis of systemic lupus erythematosus. JAMA. 177:1961;131-133.
11. Robitaille P., Tan E.M. Relationship between deoxyribonucleoprotein and deoxyribonucleic acid antibodies in systemic lupus erythematosus. J Clin Invest. 52:1973;316-323.
12. Tan E.M., Schur P.H., Carr R.I., Kunkel H.G. Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. J Clin Invest. 45:1966;1732-1740.
13. Wold R.T., Young F.E., Tan E.M., Farr R.S. Deoxyribonucleic acid antibody: a method to detect its primary interaction with deoxyribonucleic acid. Science. 161:1968;806-807.
14. Aarden L.A., de Groot Els R., Feltkamp T.E.W. Immunology of DNA III. Crithidia luciliae, a simple substrate for the determination of anti-dsDNA with the immunofluorescence technique. Ann NY Acad Sci. 254:1975;505-515.
15. Karsh J., Halbert S.P., Anken M., Klima E., Steinberg A.D. Anti-DNA, anti-deoxyribonucleoprotein and rheumatoid factor measured by ELISA in patients with systemic lupus erythematosus, Sjogren's syndrome and rheumatoid arthritis. Int Arch Allergy Appl Immunol. 68:1982;60-69.
16. Cohen A.S., Reynolds W.E., Franklin E.C., et al. Preliminary criteria for the classification of systemic lupus erythematosus. Bull Rheum Dis. 21:1971;643-648.
17. Tan E.M., Cohen A.S., Fries J.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25:1983;1271-1277.
18. Hochberg M.C. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 9:1997;1725.
19. Fritzler M.J., Tan E.M. Antibodies to histones in drug-induced lupus and idiopathic lupus erythematosus. J Clin Invest. 62:1978;560-567.
20. Burlingame R.W., Rubin R.L. Subnucleosome structures as substrates in enzyme-linked immunosorbent assays. J Immunol Methods. 134:1990;187-199.
21. Wallace D.J., Lin H.C., Shen G.Q., et al. Antibodies to histone (H2A-H2B)-DNA complexes in the absence of antibodies to double-stranded DNA or to (H2A-H2B) complexes are more sensitive and specific for scleroderma-related disorders than for lupus. Arthritis Rheum. 37:1994;1795-1797.
22. Schlumberger W., Daehnrich C., Frahm S., et al. Diagnostic relevance of autoantibodies against nucleosomes. Autoimmun Rev. 1:2002;32.
23. Amoura Z., Koutouzov A., Chabre H., et al. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases. Arthritis Rheum. 43:2000;76-84.
24. Hmida Y., Schmit P., Gilson G., Humbel R.L. Failure to detect antinucleosome antibodies in scleroderma: comment on the article by Amoura et al. Arthritis Rheum. 46:2002;280-282.
25. Burlingame R.W., Rubin R.L. Histones. van Venrooij W.J., Maini R.N. Manual of Biological Markers of Disease, Section B: The Autoantigens. 1994;B2.2/1-B2.2/18 Kluwer Academic Publishers Group, Dordrecht, The Netherlands.
26. Stemmer C., Muller S. Peter J.B., Shoenfeld Y. Histone Autoantibodies Other Than (H2A-H2B)-DNA Autoantibodies. 1996;373-384 Elsevier Science, New York.
27. Burlingame R.W. The clinical utility of antihistone antibodies. Autoantibodies reactive with chromatin in systemic lupus erythematosus and drug-induced lupus. Clin Lab Med. 17:1997;367-377.
28. Cacoub P., Musset L., Amoura Z., et al. Anticardiolipin, anti-beta2-glycoprotein I, and antinucleosome antibodies in hepatitis C virus infection and mixed cryoglobulinemia. Multivirc Group. J Rheumatol. 24:1997;2139-2144.
29. Bruns A., Blass S., Hausdorf G., et al. Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus. Arthritis Rheum. 43:2000;2307-2315.
30. Min D.J., Kim S.J., Park S.H., et al. Anti-nucleosome antibody: significance in lupus patients lacking anti-double-stranded DNA antibody. Clin Exp Rheumatol. 20:2002;13-18.
31. Cervera R., Viñas O., Ramos-Casals M., et al. Antichromatin antibodies in systemic lupus erythematosus: a useful marker for lupus nephropathy. Arthritis Rheum. 44:2001;S247 (suppl).
32. Li L., Chen M., Huang D.Y., Nishioka M. Frequency and significance of antibodies to chromatin in autoimmune hepatitis type I. J Gastroenterol Hepatol. 15:2000;1176-1182.
33. Williams R.C., Malone C.C., Meyers C., et al. Detection of nucleosome core particles in serum and plasma from patients with systemic lupus erythematosus using monoclonal antibody 4H7. J Rheumatol. 28:2001;81-94.
34. Kramers C., Hylkema M.N., van Bruggen M.C., et al. Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo. J Clin Invest. 94:1994;568-577.
35. Burlingame R.W., Rubin R.L., Balderas R.S., et al. Genesis and evolution of antichromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen. J Clin Invest. 91:1993;1687-1696.
36. Amoura Z., Chabre H., Koutouzov S., et al. Nucleosome-restricted antibodies are detected before anti-dsDNA and/or antihistone antibodies in serum of MRL-Mp lpr/lpr and +/+ mice, and are present in kidney eluates of lupus mice with proteinuria. Arthritis Rheum. 37:1994;1684-1688.
37. Kono DH, Burlingame RW, Owens DG, et al. Lupus susceptibility loci in New Zealand mice. Proc Natl Acad Sci USA 1994;91:10168-72.
38. Mohan C., Alas E., Morel L., et al. Genetic dissection of SLE pathogenesis. Sle1 on murine chromosome 1 leads to a selective loss of tolerance to H2A/H2B/DNA subnucleosomes. J Clin Invest. 101:1998;1362-1372.
39. Morel L., Croker B.P., Blenman K.R., et al. Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. Proc Natl Acad Sci USA. 97:2000;6670-6675.
40. Morel L., Blenman K.R., Croker B.P., Wakeland E.K. The major murine systemic lupus erythematosus susceptibility locus, SLE1, is a cluster of functionally related genes. Proc Natl Acad Sci USA. 98:2001;1787-1792.